Skip to main content
. 2024 Oct 1;15(5):2069–2083. doi: 10.14336/AD.2024.0103

Table 1.

Overview of the results of all the studies included in the review.

Study Glaucoma (n) Control (n) Age of glaucoma patients (mean ± SD) Biochemical method Sampling sites Markers Cellular localization Results
Hernandez et al. 1994 7 9 N/A ISH and RT-PCR ONH Collagen type IV Astrocytes ↑ in the LC sections and produced by astrocyte
Neufeld et al. 1997 8 6 79±12.3 IHC ONH COX-1 and COX-2 Astrocytes ↑COX-1 in astrocytes; Faint COX-2 staining
Pena et al. 1999 15 11 76.1±12.6 IF ONH Tenascin C Astrocytes ↑ of Tenascin in ON, LC, and post-lamina region
Yuan et al. 2000 20 20 79±14 IHC ONH TNF-a and TNF-a receptor 1 Astrocytes ↑ TNF-a and TNFR1 parallel to the disease progression
Yan et al. 2000 11 4 78.5±5.05 IHC ONH MMPs, TNF-α, and TNF-α receptor 1 Glial cells ↑ the intensity of staining and the number of glial cells.
Tezel et al. 2000 6 6 72.25±10.8 IHC ONH and Retina HSP 60 and 27 Astrocytes and RGCs ↑ HSP 60: RGCs and photoreceptors. HSP27: NFL, RGCs, and retinal vessels
Tezel et al. 2001 20 20 78±9 IHC Retina TNF-a and TNF-a receptor 1 Astrocytes and RGCs ↑ TNF-a in glial cells and TNF-R1 in the RGCs
Yang et al. 2001 6 6 69.2±14.93 IHC LC-cross sections HLA-DR Astrocytes ↑HLA-DR expression; localised with GFAP positive cells
Yuan et al. 2001 20 20 79 ±17 IHC ONH TGF-B1, B2, TNF-α, TNF-R1, COX-1, COX-2, NOS-2, c-fms, MMP-1. MMP-2, MMP-3, MMP14, TIMP1, TIMP2. TSP, CD68, PCNA, HSP27 Microglia Activated microglia with ↑ in TGF-β2, TNF-α, TNF-R1, COX-1, COX-2, NOS-2, c-fms, MMP-1, TIMP-1, TIMP-2, TSP, CD68, PCNA
Surgucheva et al. 2002 4 6 68.25±4.92 IHC ON Synucleins Glial cells ↑ γ-synuclein in a subset of glial cells in the LC and post-LC regions
Tezel et al. 2003 30 20 80.33±8.98 IHC Retina phosphorylated MAPKs Micro and Macroglia ↑ in p-ERK in glial cells and ↑ p-JNK and p-38 in the RCG layer.
Tezel et al. 2004 28 20 80.4±9.3 IHC ONH and retina HIF-1a RGC and glial cells ↑ HIF-1a in glial cells and RGCs; parallel to the visual defect
Wang et al. 2006 16 10 82.7 ± 9.3 IHC ONH Endothelin B receptor Astrocytes ↑ ETbR in astrocytic processes
Tezel et al. 2007 38 30 76.84±11.06 IHC ONH and Retina AGE and RAGE Astrocytes ↑ extracellular accumulation of AGEs and localization of RAGEs to RGCs and footplates of the Müller cells
Rudzinski et al. 2008 8 8 N/A RT-PCR and IHC ONH VEGF, PDGF and collagen XVIII Astrocytes ↓VEGF-C and PDGF-A in LC and ↑collagen XVIII and ADAMTSL-3 in LC.
Felichenfeld et al. 2008 5 4 77±9 IHC ONH Nitrotyrosine Astrocytes ↑ Nitrotyrosine in the pre-laminar ONH blood vessels and glial tissue surrounding the pre-laminar ONH
Luo et al. 2010 10 10 84.7 ± 8 IHC and LC-MS/MS Retina TLR-2, 3 and 4 Astrocytes and Microglia LC-MS/MS showed ↑ TLR signalling localised to astrocytes and microglia.
Tezel et al. 2010 38 30 76.8 ± 11 LC-MS and IHC Retina CFH, CD35, and CD59. Whole tissues Immunolabeling of the complement components and the membrane complex in ILs, including the RGCs and IPLs with regional
Yang et al. 2011 38 30 76.8 ± 11 LC-MS/MS, IHC, and WB Retina TNF-a and TNF-a receptor 1 Astrocytes and RGCs ↑ TNFR1-related downstream proteins, regulators of TNFR1 signalling, and TNFAIP3 were upregulated.
Mizokami et al. 2011 1 1 N/A IHC ONH AQP-9 and AQP-4 Glial cells ↑AQP9 co-localized in the glial cells; no change in the AQP4 expression levels
Kerr et al. 2011 2 3 78± 11.3 IHC ONH and retina Connexin43 Astrocytes ↑ Connexin43 localized in the LC and near blood vessels and the RGC layer
Reszec et al. 2012 42 2 N/A IHC ONH and retina HIF-1a Whole tissue ↑ HIF-1a in ON RGCs at the perinuclear and cytoplasmic granular regions.
Goldhagen et al. 2012 10 10 76.5±6.34 IHC ONH RhoA, ROCK-1, and ROCK-2 Whole tissue ↑ RhoA, ROCK-1, and ROCK-2 in the ONH localised to prelaminar and laminar regions
Gramlich et al. 2013 6 9 N/A IF Retina IgG accumulation Whole tissue IgG deposition in the glaucomatous retina and CD3+/IgG+ plasma cells detected
Funke et al. 2016 4 4 86±9 LC-MS/MS and IHC for validation Retina ANT3, MeCp2, DFS70 Whole tissue LC-MS/MS based analysis of proteome alterations in glaucoma.
Margeta et al. 2018 13 12 79.39±12.90 IHC ON CD163 and CD68 for macrophage infiltration Macrophages CD163+ macrophages infiltrated the ONH in glaucoma
Belmares et al. 2018 12 12 N/A Chemical staining and IF ONH and TM Collagen, elastin, Galectin and TGFB2RII Whole tissue ↑ in elastin, collagen staining in the glaucomatous ONH. Elastin fibres showed thickening and curling in the LC collagen matrix. ↑ in Galectin and TGFB2II expression glaucomatous ONH, MTZ
Chauhan et al. 2019 12 11 70.3 ± 10.5 IHC, lipidomics ONH GBA, GBA2, ASAH1, and ASAH2 Whole tissue ↑ in glucosyl sphingosine in glaucoma and mirrored changes in GBA, GBA2, ASAH1, and ASAH2
Guan et al. 2022 27 19 75.8 ± 8.0 IHC LC-cross sections F-actin and GFAP Astrocytes and Microglia ↓ GFAP and F-actin area fraction in glaucoma patients. ISH showed the presence of astrocytes and microglia
Neufeld 1999 11 6 63 ± 10 IHC ONH HLA-DR and CD45 Astrocytes and Microglia Quiescent microglia were Stellate cells with thin, ramified processes, positive for HLA-DR and CD45 but GFAP negative, while activated cells were ameboid, larger, and clustered in compressed LC
Neufeld et al. 1997 12 14 74 IHC ONH NOS-1, NOS-2, and NOS-3 Astrocytes NOS-1: prelaminar region, LC, and inside the diminished nerve fibre bundles. NOS-2: few cells in the disorganized LC. NOS-3: astrocytes and in the vascular endothelia of large and small vessels
Wang et al. 2002 10 7 87.1 ± 6.9 IHC Retina GFAP Glial cells Increased density of glial cells with deformed end feet in the peripapillary region. The glial cells were activated in the glaucomatous samples

Abbreviations: ISH: insitu hybridisation; RT-PCR: Reverse transcription Polymerase Chain Reaction, IHC: Immunohistochemistry, LC-MS/MS: Liquid-chromatography coupled mass-spectrometry, WB: Western Blot, IF: Immunofluorescence, ONH: optic nerve head, COX: cyclooxygenase, TNF: tumor necrosis factor, MMP: Matrix metalloproteinase, HSP: heat shock protein, TGF: transforming growth factor, NOS-2: nitric oxide synthase -2, c-fms: Colony-stimulating factor-1 receptor, TIMP: tissue inhibitor of metalloproteinases, TSP: thrombospondin, CD: Cluster of differentiation, PCNA: proliferating cell nuclear antigen, HLA-DR: human leukocyte antigen-DR subtype, HIF-1a: Hypoxia-inducible factor 1-alpha, MAPKs: Mitogen-activated protein kinases, AGEs: Advanced Glycation End Products, RAGE: receptor for advanced glycation end products, VEGF: Vascular endothelial growth factor, PDGF: Platelet-derived growth factor, TLR: Toll-like receptor, CFH: Complement factor H, AQP: Aquaporin, RhoA: Ras homolog family member A, ROCK: Rho-associated protein kinase, IgG: Immunoglobulin G, ANT3: ADP/ATP translocase 3, MeCp2: methyl-CpG-binding protein 2, DFS70: SRFS1-interacting protein 1, GBA: glucocerebrosidase, ASAH: acylsphingosine amidohydrolase, GFAP: Glial fibrillary acidic protein, LC: lamina cribrosa, RGC: retinal ganglion cells, NFL: Nerve fibre layer, IPL: inner plexiform layer